CATTRINI, CARLO
 Distribuzione geografica
Continente #
EU - Europa 3.608
AS - Asia 438
NA - Nord America 365
Continente sconosciuto - Info sul continente non disponibili 131
SA - Sud America 45
AF - Africa 8
Totale 4.595
Nazione #
IT - Italia 3.522
US - Stati Uniti d'America 341
SG - Singapore 175
CN - Cina 110
VN - Vietnam 85
BD - Bangladesh 31
FR - Francia 26
BR - Brasile 23
FI - Finlandia 23
HK - Hong Kong 12
CA - Canada 9
AR - Argentina 8
DE - Germania 7
GB - Regno Unito 7
JP - Giappone 7
MX - Messico 6
ES - Italia 5
PE - Perù 5
CO - Colombia 3
HN - Honduras 3
IN - India 3
RU - Federazione Russa 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
AL - Albania 2
EC - Ecuador 2
ID - Indonesia 2
IE - Irlanda 2
JM - Giamaica 2
LT - Lituania 2
MA - Marocco 2
NI - Nicaragua 2
PH - Filippine 2
PY - Paraguay 2
UA - Ucraina 2
VE - Venezuela 2
BH - Bahrain 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GR - Grecia 1
IQ - Iraq 1
JO - Giordania 1
KW - Kuwait 1
LB - Libano 1
MU - Mauritius 1
NL - Olanda 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
RE - Reunion 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 4.464
Città #
Genova 1.557
Genoa 1.281
Rapallo 337
Vado Ligure 312
Singapore 89
San Jose 75
Ashburn 44
Beijing 25
Lauterbourg 24
Helsinki 23
Ho Chi Minh City 23
Hanoi 18
New York 16
Council Bluffs 11
Hong Kong 11
Santa Clara 7
Dallas 6
Tokyo 6
Atlanta 5
Frankfurt am Main 5
Los Angeles 5
Mexico City 5
Washington 4
Buffalo 3
City of London 3
Las Vegas 3
Montreal 3
San Antonio 3
Verona 3
Ân Thi 3
Anna 2
Azusa 2
Biên Hòa 2
Blair 2
Boardman 2
Bordighera 2
Bridgeport 2
Brooklyn 2
Can Tho 2
Cape Town 2
Chicago 2
Cleveland 2
Dublin 2
Hinesville 2
Hoover 2
Indpls 2
Jakarta 2
Kingston 2
Madrid 2
Managua 2
Milan 2
Nantong 2
Naples 2
Nashville 2
Newark 2
Nuremberg 2
Olivehurst 2
Philadelphia 2
Queens 2
Rome 2
San Francisco 2
Seattle 2
Shanghai 2
Springfield 2
Tianjin 2
Tirana 2
Turin 2
Vilnius 2
Wilson 2
Addis Ababa 1
Adel 1
Agropoli 1
Albuquerque 1
Amman 1
Amsterdam 1
Aquidauana 1
Arlington 1
Armavir 1
Athens 1
Barquisimeto 1
Baton Rouge 1
Bellefontaine 1
Bitonto 1
Blairsville 1
Bogotá 1
Bologna 1
Bonita Springs 1
Boothbay 1
Bowie 1
Boydton 1
Brescia 1
Buenos Aires 1
Bắc Ninh 1
Bến Cầu 1
Campagnano di Roma 1
Canoas 1
Cao Lanh 1
Cardiff 1
Casablanca 1
Catamarca 1
Totale 4.019
Nome #
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome 257
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer 214
Androgen-deprivation therapy is more than palliation in oligometastatic prostate cancer 202
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: A mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes 197
A hnRNP K–AR-related signature reflects progression toward castration-resistant prostate cancer 197
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials 197
Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study 189
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer 185
Genitourinary tumours in the targeted therapies era: New advances in clinical practice and future perspectives 175
Targeting androgen-independent pathways: new chances for patients with prostate cancer? 175
Immunotherapy for genitourinary cancer: State of the art and new perspectives 174
Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study 171
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients 165
Bone metastases from prostate cancer: hormonal therapy 164
A large SEER- based study of survival trends in patients with de novo metastatic prostate cancer 155
Lipidomic profiling in patients with metastatic castration-resistant prostate cancer (mCRPC) 147
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study 146
To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone 146
Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experience 145
Etoposide and topoisomerase II inhibition for aggressive prostate cancer: Data from a translational study 144
Abiraterone acetate (AA) in pre- and post-docetaxel (DX) setting for metastatic castration resistant prostate cancer (mCRPC): a monoinstitutional experience focused on cardiovascular events and on their impact on clinical outcomes 142
Atezolizumab and bladder cancer: facing a complex disease 127
BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications 126
EFFICACY AND SAFETY OF SUNITINIB AND EVEROLIMUS AS FRONTLINE TREATMENT FOR NON-CC-RCC: A POOLED-ANALYSIS FROM RANDOMIZED TRIALS 124
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer 111
Combination therapy in metastatic renal cell carcinoma: Back to the future? 109
Real-world survival improvements in patients with newly diagnosed metastatic prostate cancer treated in the United States 107
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer 107
Medical Liability in Cancer Care During COVID-19 Pandemic: Heroes or Guilty? 57
null 40
Totale 4.595
Categoria #
all - tutte 15.452
article - articoli 14.551
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 494
Totale 30.497


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022344 15 10 16 30 16 40 7 85 25 35 25 40
2022/2023388 28 47 3 37 79 55 0 30 50 7 47 5
2023/2024306 10 63 8 43 10 55 12 8 10 16 11 60
2024/2025830 30 47 26 72 88 75 94 176 16 34 89 83
2025/20261.282 169 18 185 80 190 63 178 51 74 128 100 46
2026/2027115 115 0 0 0 0 0 0 0 0 0 0 0
Totale 4.595